TREKKA is an early-stage biomaterials company spun-out from the University of Minnesota, that was formed to commercialize and develop advanced polymeric excipients to improve the efficacy and safety of drugs. The building block is a proprietary CAPRO Polymer Drug Delivery Platform, that is a novel solution to address the challenges of controlled delivery of poorly soluble small molecule drugs, biologics (peptides, proteins, nucleic acids, vaccines), and drug combinations. Firm's current strategic pathway is to commercialize our technology platforms and internally developed products through licensing, strategic partnering, and profit-sharing joint ventures. This ensures that drug delivery platform will be utilized and leveraged to help accelerate productivity and innovation across the industry.
